97648630 - B

Information

• Trademark
• 97648630

• Source

• Serial Number

  97648630

• Registration Number

  7476146

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 39 - Transport
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 26, 2022
  2 years ago

• Registration Date

  August 13, 2024
  5 months ago

• Transaction Date

  August 13, 2024
  5 months ago

• Status Date

  August 13, 2024
  5 months ago

• Published for Opposition Date

  September 19, 2023
  a year ago

• Location Date

  July 07, 2024
  6 months ago

• First Use Anywhere Date

  September 08, 2022
  2 years ago

• First Use In Commerce Date

  September 08, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BECHHOFER, YOCHEVED D

• Attorney Docket Number

  09799037-126

  Attorney Name

  Tara Reedy Sliva

  Law Office Assigned Location Code

  M50

• Owners

  • BIOSYNTH AS

Case File Statements

• GS0401: Custom manufacture of medicines and diagnostics for others; Custom manufacturing for others in the pharmaceutical, diagnostic, veterinary, biotechnology and chemistry fields
• DM0000: The mark consists of the stylized letter B with an angle design on the bottom left of the B.
• GS0391: Packaging and filling articles to the order and specification of others; Warehouse services
• GS0051: Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
• PM0001: BIOSYNTH
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
• GS0421: Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics

Case File Event Statements

• 10/29/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/9/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/10/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 8/9/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/11/2023 - a year ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/30/2023 - a year ago

  6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/19/2023 - a year ago

  7 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/19/2023 - a year ago

  8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/14/2023 - a year ago

  9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 4/26/2024 - 8 months ago

  12 - USE AMENDMENT FILED Type: IUAF

• 4/26/2024 - 8 months ago

  10 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 5/25/2024 - 7 months ago

  11 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 5/25/2024 - 7 months ago

  13 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 7/7/2024 - 6 months ago

  14 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 7/7/2024 - 6 months ago

  15 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 8/13/2024 - 5 months ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/13/2024 - 5 months ago

  17 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC